Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI predict your lifespan from a short video?

NCT ID NCT07808619

Diagnosis Sponsor: Longevity Metrics, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers are building AI models that score standard physical and cognitive screening tests from video and audio, and that predict results a person did not obtain. The study enrolls adults 18 and older and follows them for life, linking records to a long-term aging study to check predictions against death and disease. The goal is to see whether a few short video clips can eventually replace most in-person screening, reaching people and places a physical lab cannot. Every model output is a physician-reviewed decision aid, not a diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-scored video and audio health screening battery
What this could lead to
If it works, preventive screening could reach people and places without a physical lab, using a few short video clips to estimate health and longevity.
What could go wrong
The models are clinical decision aids, not diagnoses, and every output needs a physician's confirmation. Predicting life expectancy and disease from video may not prove accurate enough to replace in-person tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Dec 2099

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants enrolled in the 100-Year Human Aging Study (NCT07563777) through the unified consent, receiving any Longevity Metrics health screening service at any fixed, mobile, or remote (online) site, current and future. Participants are self-selected community members of all health statuses; no exclusions based on health status, diagnosis, or population group. This study adds no separate enrollment: all records analyzed and all prospective measurements collected under this protocol arise from participants consented under the associated protocols. Participants are followed for life, with mortality, incident disease, and functional-status outcomes ascertained through linkage to the 100-Year Human Aging Study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>= 18 * willing to participate in the study Exclusion Criteria: * Age \< 18 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Activities of daily living are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome cardiovascular disorder cognitive disorder Cognitive Dysfunction Frailty metabolic syndrome X musculoskeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Activities of daily living Aging Cardiovascular disease prevention Cognitive dysfunction Diagnostic techniques and procedures Frailty Health services accessibility Metabolic syndrome Mortality Musculoskeletal diseases Physical disability Preventive health services

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Longevity Metrics

    RECRUITING

    Boulder, Colorado, 80301, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.